Logiscreen

ArriVent BioPharma Inc

$29.98
Market Cap 1.33B
ROE -49.0%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 14.0
Revenue QoQ 0.0%
EPS QoQ -0.5%
F-Score 3

About

ArriVent BioPharma Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-10.25
vs median 37.08
P/B
4.60
vs median 2.65
ROE
-0.49
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

MAZENVAXXERSINNVMRVIKARD
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics